ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gastrointestinal Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-3O396
Home | Market Reports | Health| Health Conditions
Global Gastrointestinal Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Gastrointestinal Market Research Report 2024

Code: QYRE-Auto-3O396
Report
February 2024
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AstraZenec
Sanofi
Bayer
Pfizer Inc
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian Janssen
GlaxoSmithKline
GlaxoSmithKline PLC
TEVA

Gastrointestinal Market Size

The global Gastrointestinal market was valued at US$ 34710 million in 2023 and is anticipated to reach US$ 43730 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

Gastrointestinal Market

Gastrointestinal Market

Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
Global Gastrointestinal key players include AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. Global top five manufacturers hold a share over 25%.
Europe is the largest market, with a share about 45%, followed by Asia, and North America, both have a share over 45 percent.
In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%. And in terms of application, the largest application is Chronic Gastritis, followed by Peptic Ulcer, etc.
This report aims to provide a comprehensive presentation of the global market for Gastrointestinal, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastrointestinal.

Report Scope

The Gastrointestinal market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gastrointestinal market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gastrointestinal companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gastrointestinal Market Report

Report Metric Details
Report Name Gastrointestinal Market
Accounted market size in 2023 US$ 34710 million
Forecasted market size in 2030 US$ 43730 million
CAGR 3.3%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Prescription Gastrointestinal Drug
  • OTC Gastrointestinal Drug
Segment by Application
  • Chronic Gastritis
  • Functional Dyspepsia
  • Peptic Ulcer
  • Acute Gastroenteritis
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gastrointestinal companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gastrointestinal Market growing?

Ans: The Gastrointestinal Market witnessing a CAGR of 3.3% during the forecast period 2024-2030.

What is the Gastrointestinal Market size in 2030?

Ans: The Gastrointestinal Market size in 2030 will be US$ 43730 million.

What is the market share of major companies in Gastrointestinal Market?

Ans: Global top five manufacturers hold a share over 25%.

What is the Gastrointestinal Market share by type?

Ans: In terms of product, Prescription Gastrointestinal Drug is the largest segment, with a share over 80%.

Who are the main players in the Gastrointestinal Market report?

Ans: The main players in the Gastrointestinal Market are AstraZenec, Sanofi, Bayer, Pfizer, GlaxoSmithKline, Teva, Zeria（Tillotts）, Perrigo, Boehringer Ingelheim, Purdue Pharma, C.B. Fleet, Abbott, Jiangzhong, Xian-Janssen

What are the Application segmentation covered in the Gastrointestinal Market report?

Ans: The Applications covered in the Gastrointestinal Market report are Chronic Gastritis, Functional Dyspepsia, Peptic Ulcer, Acute Gastroenteritis, Others

What are the Type segmentation covered in the Gastrointestinal Market report?

Ans: The Types covered in the Gastrointestinal Market report are Prescription Gastrointestinal Drug, OTC Gastrointestinal Drug

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Market Perspective (2019-2030)
2.2 Gastrointestinal Growth Trends by Region
2.2.1 Global Gastrointestinal Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gastrointestinal Historic Market Size by Region (2019-2024)
2.2.3 Gastrointestinal Forecasted Market Size by Region (2025-2030)
2.3 Gastrointestinal Market Dynamics
2.3.1 Gastrointestinal Industry Trends
2.3.2 Gastrointestinal Market Drivers
2.3.3 Gastrointestinal Market Challenges
2.3.4 Gastrointestinal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Players by Revenue
3.1.1 Global Top Gastrointestinal Players by Revenue (2019-2024)
3.1.2 Global Gastrointestinal Revenue Market Share by Players (2019-2024)
3.2 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Revenue
3.4 Global Gastrointestinal Market Concentration Ratio
3.4.1 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Revenue in 2023
3.5 Gastrointestinal Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Product Solution and Service
3.7 Date of Enter into Gastrointestinal Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Breakdown Data by Type
4.1 Global Gastrointestinal Historic Market Size by Type (2019-2024)
4.2 Global Gastrointestinal Forecasted Market Size by Type (2025-2030)
5 Gastrointestinal Breakdown Data by Application
5.1 Global Gastrointestinal Historic Market Size by Application (2019-2024)
5.2 Global Gastrointestinal Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gastrointestinal Market Size (2019-2030)
6.2 North America Gastrointestinal Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gastrointestinal Market Size by Country (2019-2024)
6.4 North America Gastrointestinal Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gastrointestinal Market Size (2019-2030)
7.2 Europe Gastrointestinal Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gastrointestinal Market Size by Country (2019-2024)
7.4 Europe Gastrointestinal Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Market Size (2019-2030)
8.2 Asia-Pacific Gastrointestinal Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gastrointestinal Market Size by Region (2019-2024)
8.4 Asia-Pacific Gastrointestinal Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gastrointestinal Market Size (2019-2030)
9.2 Latin America Gastrointestinal Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gastrointestinal Market Size by Country (2019-2024)
9.4 Latin America Gastrointestinal Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Market Size (2019-2030)
10.2 Middle East & Africa Gastrointestinal Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gastrointestinal Market Size by Country (2019-2024)
10.4 Middle East & Africa Gastrointestinal Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZenec
11.1.1 AstraZenec Company Detail
11.1.2 AstraZenec Business Overview
11.1.3 AstraZenec Gastrointestinal Introduction
11.1.4 AstraZenec Revenue in Gastrointestinal Business (2019-2024)
11.1.5 AstraZenec Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Detail
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Gastrointestinal Introduction
11.2.4 Sanofi Revenue in Gastrointestinal Business (2019-2024)
11.2.5 Sanofi Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Gastrointestinal Introduction
11.3.4 Bayer Revenue in Gastrointestinal Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gastrointestinal Introduction
11.4.4 Pfizer Revenue in Gastrointestinal Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Gastrointestinal Introduction
11.5.4 GlaxoSmithKline Revenue in Gastrointestinal Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Teva
11.6.1 Teva Company Detail
11.6.2 Teva Business Overview
11.6.3 Teva Gastrointestinal Introduction
11.6.4 Teva Revenue in Gastrointestinal Business (2019-2024)
11.6.5 Teva Recent Development
11.7 Zeria（Tillotts）
11.7.1 Zeria（Tillotts） Company Detail
11.7.2 Zeria（Tillotts） Business Overview
11.7.3 Zeria（Tillotts） Gastrointestinal Introduction
11.7.4 Zeria（Tillotts） Revenue in Gastrointestinal Business (2019-2024)
11.7.5 Zeria（Tillotts） Recent Development
11.8 Perrigo
11.8.1 Perrigo Company Detail
11.8.2 Perrigo Business Overview
11.8.3 Perrigo Gastrointestinal Introduction
11.8.4 Perrigo Revenue in Gastrointestinal Business (2019-2024)
11.8.5 Perrigo Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Detail
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Gastrointestinal Introduction
11.9.4 Boehringer Ingelheim Revenue in Gastrointestinal Business (2019-2024)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Detail
11.10.2 Purdue Pharma Business Overview
11.10.3 Purdue Pharma Gastrointestinal Introduction
11.10.4 Purdue Pharma Revenue in Gastrointestinal Business (2019-2024)
11.10.5 Purdue Pharma Recent Development
11.11 C.B. Fleet
11.11.1 C.B. Fleet Company Detail
11.11.2 C.B. Fleet Business Overview
11.11.3 C.B. Fleet Gastrointestinal Introduction
11.11.4 C.B. Fleet Revenue in Gastrointestinal Business (2019-2024)
11.11.5 C.B. Fleet Recent Development
11.12 Abbott
11.12.1 Abbott Company Detail
11.12.2 Abbott Business Overview
11.12.3 Abbott Gastrointestinal Introduction
11.12.4 Abbott Revenue in Gastrointestinal Business (2019-2024)
11.12.5 Abbott Recent Development
11.13 Jiangzhong
11.13.1 Jiangzhong Company Detail
11.13.2 Jiangzhong Business Overview
11.13.3 Jiangzhong Gastrointestinal Introduction
11.13.4 Jiangzhong Revenue in Gastrointestinal Business (2019-2024)
11.13.5 Jiangzhong Recent Development
11.14 Xian-Janssen
11.14.1 Xian-Janssen Company Detail
11.14.2 Xian-Janssen Business Overview
11.14.3 Xian-Janssen Gastrointestinal Introduction
11.14.4 Xian-Janssen Revenue in Gastrointestinal Business (2019-2024)
11.14.5 Xian-Janssen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
AstraZenec
Sanofi
Bayer
Pfizer Inc
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Purdue Pharma
C.B. Fleet
Abbott
Jiangzhong
Xian Janssen
GlaxoSmithKline
GlaxoSmithKline PLC
TEVA
List of Tables
    Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Prescription Gastrointestinal Drug
    Table 3. Key Players of OTC Gastrointestinal Drug
    Table 4. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Gastrointestinal Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Gastrointestinal Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Gastrointestinal Market Share by Region (2019-2024)
    Table 8. Global Gastrointestinal Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Gastrointestinal Market Share by Region (2025-2030)
    Table 10. Gastrointestinal Market Trends
    Table 11. Gastrointestinal Market Drivers
    Table 12. Gastrointestinal Market Challenges
    Table 13. Gastrointestinal Market Restraints
    Table 14. Global Gastrointestinal Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Gastrointestinal Market Share by Players (2019-2024)
    Table 16. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal as of 2023)
    Table 17. Ranking of Global Top Gastrointestinal Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Gastrointestinal Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gastrointestinal Product Solution and Service
    Table 21. Date of Enter into Gastrointestinal Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gastrointestinal Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Gastrointestinal Revenue Market Share by Type (2019-2024)
    Table 25. Global Gastrointestinal Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Gastrointestinal Revenue Market Share by Type (2025-2030)
    Table 27. Global Gastrointestinal Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Gastrointestinal Revenue Market Share by Application (2019-2024)
    Table 29. Global Gastrointestinal Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Gastrointestinal Revenue Market Share by Application (2025-2030)
    Table 31. North America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Gastrointestinal Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Gastrointestinal Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Gastrointestinal Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Gastrointestinal Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Gastrointestinal Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Gastrointestinal Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Gastrointestinal Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Gastrointestinal Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Gastrointestinal Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Gastrointestinal Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Gastrointestinal Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Gastrointestinal Market Size by Country (2025-2030) & (US$ Million)
    Table 46. AstraZenec Company Detail
    Table 47. AstraZenec Business Overview
    Table 48. AstraZenec Gastrointestinal Product
    Table 49. AstraZenec Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 50. AstraZenec Recent Development
    Table 51. Sanofi Company Detail
    Table 52. Sanofi Business Overview
    Table 53. Sanofi Gastrointestinal Product
    Table 54. Sanofi Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 55. Sanofi Recent Development
    Table 56. Bayer Company Detail
    Table 57. Bayer Business Overview
    Table 58. Bayer Gastrointestinal Product
    Table 59. Bayer Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 60. Bayer Recent Development
    Table 61. Pfizer Company Detail
    Table 62. Pfizer Business Overview
    Table 63. Pfizer Gastrointestinal Product
    Table 64. Pfizer Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 65. Pfizer Recent Development
    Table 66. GlaxoSmithKline Company Detail
    Table 67. GlaxoSmithKline Business Overview
    Table 68. GlaxoSmithKline Gastrointestinal Product
    Table 69. GlaxoSmithKline Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 70. GlaxoSmithKline Recent Development
    Table 71. Teva Company Detail
    Table 72. Teva Business Overview
    Table 73. Teva Gastrointestinal Product
    Table 74. Teva Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 75. Teva Recent Development
    Table 76. Zeria（Tillotts） Company Detail
    Table 77. Zeria（Tillotts） Business Overview
    Table 78. Zeria（Tillotts） Gastrointestinal Product
    Table 79. Zeria（Tillotts） Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 80. Zeria（Tillotts） Recent Development
    Table 81. Perrigo Company Detail
    Table 82. Perrigo Business Overview
    Table 83. Perrigo Gastrointestinal Product
    Table 84. Perrigo Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 85. Perrigo Recent Development
    Table 86. Boehringer Ingelheim Company Detail
    Table 87. Boehringer Ingelheim Business Overview
    Table 88. Boehringer Ingelheim Gastrointestinal Product
    Table 89. Boehringer Ingelheim Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 90. Boehringer Ingelheim Recent Development
    Table 91. Purdue Pharma Company Detail
    Table 92. Purdue Pharma Business Overview
    Table 93. Purdue Pharma Gastrointestinal Product
    Table 94. Purdue Pharma Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 95. Purdue Pharma Recent Development
    Table 96. C.B. Fleet Company Detail
    Table 97. C.B. Fleet Business Overview
    Table 98. C.B. Fleet Gastrointestinal Product
    Table 99. C.B. Fleet Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 100. C.B. Fleet Recent Development
    Table 101. Abbott Company Detail
    Table 102. Abbott Business Overview
    Table 103. Abbott Gastrointestinal Product
    Table 104. Abbott Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 105. Abbott Recent Development
    Table 106. Jiangzhong Company Detail
    Table 107. Jiangzhong Business Overview
    Table 108. Jiangzhong Gastrointestinal Product
    Table 109. Jiangzhong Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 110. Jiangzhong Recent Development
    Table 111. Xian-Janssen Company Detail
    Table 112. Xian-Janssen Business Overview
    Table 113. Xian-Janssen Gastrointestinal Product
    Table 114. Xian-Janssen Revenue in Gastrointestinal Business (2019-2024) & (US$ Million)
    Table 115. Xian-Janssen Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Gastrointestinal Market Share by Type: 2023 VS 2030
    Figure 3. Prescription Gastrointestinal Drug Features
    Figure 4. OTC Gastrointestinal Drug Features
    Figure 5. Global Gastrointestinal Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Gastrointestinal Market Share by Application: 2023 VS 2030
    Figure 7. Chronic Gastritis Case Studies
    Figure 8. Functional Dyspepsia Case Studies
    Figure 9. Peptic Ulcer Case Studies
    Figure 10. Acute Gastroenteritis Case Studies
    Figure 11. Others Case Studies
    Figure 12. Gastrointestinal Report Years Considered
    Figure 13. Global Gastrointestinal Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Gastrointestinal Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Gastrointestinal Market Share by Region: 2023 VS 2030
    Figure 16. Global Gastrointestinal Market Share by Players in 2023
    Figure 17. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Revenue in 2023
    Figure 19. North America Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Gastrointestinal Market Share by Country (2019-2030)
    Figure 21. United States Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Gastrointestinal Market Share by Country (2019-2030)
    Figure 25. Germany Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. France Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. U.K. Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Italy Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Russia Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Nordic Countries Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Gastrointestinal Market Share by Region (2019-2030)
    Figure 33. China Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Japan Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. South Korea Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Southeast Asia Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. India Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Australia Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Gastrointestinal Market Share by Country (2019-2030)
    Figure 41. Mexico Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Brazil Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Gastrointestinal Market Share by Country (2019-2030)
    Figure 45. Turkey Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Saudi Arabia Gastrointestinal Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. AstraZenec Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 48. Sanofi Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 49. Bayer Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 50. Pfizer Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 51. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 52. Teva Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 53. Zeria（Tillotts） Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 54. Perrigo Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 55. Boehringer Ingelheim Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 56. Purdue Pharma Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 57. C.B. Fleet Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 58. Abbott Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 59. Jiangzhong Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 60. Xian-Janssen Revenue Growth Rate in Gastrointestinal Business (2019-2024)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Respiratory Infection Diagnostic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39D3651
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Internal Neuromodulation Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-24F2529
Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Colon Cancer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-31C5944
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10J13802
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions